Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), renowned for its pioneering platform in cell programming and biosecurity, is excited to announce that its Chief Financial Officer, Mark Dmytruk, will be a featured speaker at the Morgan Stanley 22nd Annual Global Healthcare Conference. The fireside chat is scheduled for Friday, September 6, at 11:30 a.m. ET.

The conference provides a prominent platform for leaders in the healthcare and biotechnology sectors to discuss the latest trends and innovations. Mark Dmytruk’s participation will offer valuable insights into Ginkgo Bioworks’ strategic initiatives and its vision for advancing cell programming and biosecurity.

Tune In and Stay Updated

For those interested in catching the discussion live or accessing a replay, further details, including a webcast link, will be available on the Ginkgo Bioworks investor relations website. Make sure to visit the site for the most up-to-date information.

About Ginkgo Bioworks

Ginkgo Bioworks stands at the forefront of cell programming, providing a comprehensive suite of services designed to address challenges across a wide range of industries. From transforming food and agriculture to innovating in pharmaceuticals and industrial chemicals, Ginkgo Bioworks is committed to creating impactful solutions. Additionally, its Ginkgo Biosecurity division is dedicated to building next-generation infrastructure and technologies to enhance global capabilities in predicting, detecting, and responding to biological threats.

To learn more about Ginkgo Bioworks and its initiatives, visit ginkgobioworks.com and ginkgobiosecurity.com. Stay connected with the latest updates and insights by following us on X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.

Source- Ginkobioworks